JONBUR Research · Initiation
KT&G · 033780 · Tobacco
KT&G: Steady Margins and Rising Profit, With the Share Price Up 33.3% Over One Year
KT&G closed at ₩180,200 on 2026-10-12, up 33.3% over one year and near the upper end of its 52-week range, with a market value of about ₩22.0T. Filed statements show trailing operating margin of 21.4% and net income of ₩1.4T, while the latest filings include a share buyback and a share cancellation decision.
Written Oct 13, 2026 · Data as of Oct 12, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a picture of a stable, highly profitable tobacco company. Revenue rose 11.4% in 2025 after two years of near-flat growth, and trailing operating margin of 21.4% is above the 2025 level of 20.4%. Trailing ROE of 15.2% is higher than any annual figure shown for 2021-2025 (9.8% to 12.7%). The stock has risen 33.3% in a year, and the P/B of 2.3 is above the year-end 2025 level of 1.9, so part of the improvement appears already reflected in the price. The data does not include investor flows, foreign ownership, short balance or peer multiples, so we cannot say who has been buying or how the company compares with similar firms. The details of the lawsuit filed or ruled on 2026-09-18 are not in the data.
Business overview
KT&G is a KOSPI-listed tobacco company (code 033780), founded on 1987-04-01 and listed on 1999-10-08. It has 122,062,497 listed shares and a market capitalization of about ₩22.0T. Revenue was ₩5.2T in 2021 and ₩6.6T in 2025. Trailing revenue as of H1 2026 was ₩6.9T. The CEO is listed as 방경만. The data does not break revenue down by product or region.
Financial analysis
Figures come from filed financial statements (DART). Revenue was ₩6.58T in 2025, up 11.4% from ₩5.91T in 2024, after growth of 0.8% in 2024 and 0.2% in 2023. Operating income was ₩1.34T in 2025 (20.4% margin), versus ₩1.19T in 2024 (20.1%) and ₩1.34T in 2021 (25.6%). Net income was ₩1.09T in 2025, down from ₩1.17T in 2024. Trailing figures to H1 2026 show revenue of ₩6.95T, operating income of ₩1.49T (21.4% margin) and net income of ₩1.44T (20.7% net margin). Balance sheet: cash of ₩1.08T against borrowings of ₩1.06T, and liabilities to equity of 54.6%. Trailing free cash flow was ₩452B.
Valuation
At the current price the P/E is 15.3, P/B 2.3, P/S 3.2 and dividend yield 2.9%. Enterprise value is about ₩22.0T. EV/EBITDA is not available. For history, the year-end 2025 P/E was 15.9 and P/B 1.9, so the P/E is slightly lower now while the P/B is higher. Earlier year-end multiples are not available, and no peer data was provided, so a comparison with similar companies cannot be made.
Catalysts
- On 2026-09-22 the company filed both a share buyback decision and a share cancellation decision, which bear on shares outstanding and shareholder returns.
- A cash dividend decision and record-date decision were filed on 2026-08-06, alongside preliminary consolidated earnings.
- The half-year report for June 2026 was filed on 2026-08-14 and is the basis for the latest trailing figures.
- Two 5%+ holding reports were filed (2026-08-05 and 2026-09-07), indicating changes in large shareholdings, though details are not in the data.
- An investor relations event was held on 2026-07-23.
Risks
- A lawsuit filing or ruling was disclosed on 2026-09-18, and its subject and potential impact are not available in the data.
- The share price is up 33.3% over one year and 4.9% over one month, with P/B above the year-end 2025 level, which leaves less room for disappointment in results.
- Net income fell from ₩1.17T in 2024 to ₩1.09T in 2025 even as revenue grew, showing that profit growth has not been steady.
- Operating margin of 21.4% remains below the 25.6% recorded in 2021, so margins have not returned to that peak.
- Investor flow, foreign ownership and short-selling data are missing, so shifts in market positioning cannot be assessed.
Closing view
The filed numbers show a consistently profitable company, with trailing margins above 20%, solid cash generation and borrowings roughly matched by cash. Recent revenue growth and a higher ROE are positives, and the buyback and cancellation filings point to attention to shareholder returns. Against this, the share price has already risen strongly, the P/B is higher than at the end of 2025, a lawsuit is disclosed without detail, and there is no peer or flow data to put the valuation in wider context. The evidence is constructive on operating quality but incomplete on relative valuation and market positioning.
Model estimate of fair value
The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).
Report history
Source: KRX statistical information